Abstract
(Abstracted from Int J Gynecol Cancer 2022;32:9–14) Because of the overwhelming pressure placed on the health care system during the COVID-19 pandemic, resource prioritization and infection risk led to deviation from standard of care treatment for women with gynecologic cancer. The loss of intensive care availability, surgical capacity, as well as radio- and systemic therapy availability particularly impacted this vulnerable population.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
